Latest News
-
May.232014NEWS
HanAll Biopharma, Achieving Net Income of 540M KRW to Turn into Surplus
HanAll Biopharma, Achieving Net Income of 540M KRW to Turn into Surplus
-
Apr.272014NEWS
Hanall Biopharma, Completed the Clinical Trial Phase 1 of \'HL036\', New Medicine for Dry Eye Disease
Hanall Biopharma, Completed the Clinical Trial Phase 1 of \'HL036\', New Medicine for Dry Eye Diseas